All stressed out: Phenoytpe plasticity and therapy resistance in melanoma

被引：0
|
作者：
Giles, Jasmin [1 ]
Biancaniello, Maria [1 ]
Fane, Mitchell [2 ]
Alicea, Gretchen [3 ]
Kossenkov, Andrew [4 ]
Kaur, Amanpreet [5 ]
Rebecca, Vito [3 ]
Xu, Xiaowei [5 ]
Herlyn, Meenhard [4 ]
Murphy, Maureen [4 ]
Weeraratna, Ashani [2 ]
Webster, Marie R. [1 ]
机构：
[1] Lankenau Inst Med Res, Wynnewood, PA USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Publ Hlth, Baltimroe, MD USA
[4] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
966
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cancer plasticity in therapy resistance: Mechanisms and novel strategies
    Niu, Xing
    Liu, Wenjing
    Zhang, Yinling
    Liu, Jing
    Zhang, Jianjun
    Li, Bo
    Qiu, Yue
    Zhao, Peng
    Wang, Zhongmiao
    Wang, Zhe
    DRUG RESISTANCE UPDATES, 2024, 76
  • [42] The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
    Beltran, Himisha
    Hruszkewycz, Andrew
    Scher, Howard I.
    Hildesheim, Jeffrey
    Isaacs, Jennifer
    Yu, Evan Y.
    Kelly, Kathleen
    Lin, Daniel
    Dicker, Adam
    Arnold, Julia
    Hecht, Toby
    Wicha, Max
    Sears, Rosalie
    Rowley, David
    White, Richard
    Gulley, James L.
    Lee, John
    Meco, Maria Diaz
    Small, Eric J.
    Shen, Michael
    Knudsen, Karen
    Goodrich, David W.
    Lotan, Tamara
    Zoubeidi, Amina
    Sawyers, Charles L.
    Rudin, Charles M.
    Loda, Massimo
    Thompson, Timothy
    Rubin, Mark A.
    Tawab-Amiri, Abdul
    Dahut, William
    Nelson, Peter S.
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 6916 - 6924
  • [43] Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance
    Singh, Mithalesh K.
    Altameemi, Sarah
    Lares, Marcos
    Newton, Michael A.
    Setaluri, Vijayasaradhi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
    Falletta, Paola
    Sanchez-del-Campo, Luis
    Chauhan, Jagat
    Effern, Maike
    Kenyon, Amy
    Kershaw, Christopher J.
    Siddaway, Robert
    Lisle, Richard
    Freter, Rasmus
    Daniels, Matthew J.
    Lu, Xin
    Tueting, Thomas
    Middleton, Mark
    Buffa, Francesca M.
    Willis, Anne E.
    Pavitt, Graham
    Ronai, Ze'ev A.
    Sauka-Spengler, Tatjana
    Hoelzel, Michael
    Goding, Colin R.
    GENES & DEVELOPMENT, 2017, 31 (01) : 18 - 33
  • [45] Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance
    Mithalesh K. Singh
    Sarah Altameemi
    Marcos Lares
    Michael A. Newton
    Vijayasaradhi Setaluri
    Scientific Reports, 12
  • [46] Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
    A Roesch
    Oncogene, 2015, 34 : 2951 - 2957
  • [47] Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
    Roesch, A.
    ONCOGENE, 2015, 34 (23) : 2951 - 2957
  • [48] Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
    Keller, Hilary R.
    Zhang, Xin
    Li, Li
    Schaider, Helmut
    Wells, James W.
    ONCOTARGET, 2017, 8 (43) : 75675 - 75686
  • [49] Antiplatelet Therapy: Aspirin Resistance and All That Jazz!
    Divani, Afshin A.
    Zantek, Nicole D.
    Borhani-Haghighi, Afshin
    Rao, Gundu H. R.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (01) : 5 - 18
  • [50] Cytoskeletal Remodelling as an Achilles' Heel for Therapy Resistance in Melanoma
    Barreno, Adrian
    Orgaz, Jose L.
    CELLS, 2022, 11 (03)
12345